Heading the charge, Bristol Myers Squibb appoints Harald Hampel as Senior Vice President and Worldwide Head of Medical Affairs

Bristol Myers Squibb’s neuroscience strategy is being reinforced by the appointment of Harald Hampel as Senior Vice President and Worldwide Head of Medical Affairs, Neuroscience, where he will guide global medical strategy in brain health.

Bristol Myers Squibb and Syngene International extended their strategic collaboration through 2035, broadening integrated services across discovery, development, manufacturing, and clinical support via the long-standing Biocon BMS Research and Development Center in Bengaluru.